Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NASDAQ:REGN) has delivered an average annual return of 12.78% over the past 10 years, outperforming the market by 2.01% on an annualized basis. A $1000 investment in REGN stock a decade ago would be worth $3,226.98 today. The company currently boasts a market capitalization of $107.43 billion.
May 14, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Regeneron Pharmaceuticals has shown a strong performance over the last decade with an average annual return of 12.78%, significantly outperforming the market. This historical performance, coupled with a current market cap of $107.43 billion, highlights the company's growth and stability.
The historical performance of Regeneron Pharmaceuticals, as detailed in the article, suggests a strong and stable growth trajectory over the past decade. This performance is likely to positively influence investor perception and could lead to increased investor confidence in the short term. The significant return on investment over a 10-year period showcases the company's ability to generate value for its shareholders, which is a positive indicator for future performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100